About Allylix
Allylix is a Healthcare company based in United States founded in 2002, and was acquired by Evolva in November 2014. Flavoring ingredients are produced from plants via yeast fermentation. It operates in the Healthcare and Agriculture sectors. Allylix has raised $36.35 million across 8 funding rounds from investors including BASF, Tate & Lyle and Evolva. Allylix offers products and services including Slots, Live Casino, Sportsbook, Arcade, and Poker. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Plant Breeding. Its competitors include Benson Hill, Cibus and Pairwise; 3 of its 3 listed competitors have raised funding.
Company details
Allylix uses plants to produce flavoring agents used in the food, pharma and agrochemical production industry. Its process involves fermentation using yeast and downstream processing (purification). Its products are made from orchid genus vanilla, saffron, sandalwood, agarwood, etc. End products are used as flavor fragrance agents in personal care products, nutrition food and pharma industries. The company was acquired by Evolva in Nov, 2014, and Cargill contributed in financing of the deal.
- Headquarters United States
- Stage Acquired
- SectorsHealthcareAgriculture
- Website allylix.com
- Social LinkedIn
- Acquired by Evolva (Nov 2014)
Products & Services of Allylix
Allylix offers a comprehensive portfolio of products and services, including Slots, Live Casino, Sportsbook, Arcade, and Poker.
Online slot games for entertainment and betting.
Live dealer games like blackjack for interactive play.
Platform for wagering on sports events online.
Variety of arcade-style games for casual betting.
Multiplayer poker rooms for online competitions.
Online lottery and betting services available.
Funding Insights of Allylix
Allylix has successfully raised a total of $36.35M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $2.5 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.35M
- Total Rounds 8
- Last Round Series D — $2.5M
- First Round $1.5M
(Aug 2005)
- Investors Count 11
All 8 funding rounds of Allylix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2014 | $2.5M | Series D | – | – | – |
| Mar 2012 | $19M | Series D | – | BASF | |
| Nov 2011 | $1M | Series C | – | – | – |
| Apr 2010 | $9M | Series C | – | Cultivian Ventures | |
| Jan 2008 | $100,000 | Grant | – | – | |
| Nov 2007 | $3.35M | Series B | – | Tate & Lyle | |
| Oct 2007 | $100,000 | Grant | – | – | |
| Aug 2005 | $1.5M | Series A | – | – | – |
12 investors in total: 12 institutional.
Investors in Allylix
Allylix has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include BASF, Tate & Lyle and Evolva.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tateandlyleventures.com | ||||
| cultiviancapital.com | ||||
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Angel Network for companies based in Southern California | techcoastangels.com | Los Angeles, United States | ||
Investments are facilitated by Pasadena Angels in Southern California startups. | 2000 | pasadenaangels.com | Altadena, United States | |
| bluegrassangels.com | ||||
Foodtech and agtech sectors are invested in by Middleland Capital. | middlelandcapital.com | Washington, Dc, United States | ||
Chemicals and related products are produced and marketed globally. | 1865 | basf.com | Florham Park, United States | |
Flexible subordinated debt financing is offered for food and agriculture companies. | 2002 | avriosubdebt.com | Calgary, Canada | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Allylix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Allylix
4 dated milestones of Allylix across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Allylix is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series D, of $2.5M.
- Exit Acquired by Evolva.
Competitors of Allylix
Allylix has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Cibus and Pairwise.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| pairwise.com | 2017 | Durham, United States | $155M | New crop varieties are developed using gene-editing for agrigenomics. |
Detailed competitors of Allylix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Allylix (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Allylix
Complete news archive for Allylix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allylix
Allylix was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Allylix is headquartered in United States.
Allylix is a funded company, having raised a total of $36.35M across 8 funding rounds to date. The company's 1st funding round was a Series A of $1.5M, raised on Aug 2005.
Allylix uses plants to produce flavoring agents used in the food, pharma and agrochemical production industry. Its process involves fermentation using yeast and downstream processing (purification). Its products are made from orchid genus vanilla, saffron, sandalwood, agarwood, etc. End products are used as flavor fragrance agents in personal care products, nutrition food and pharma industries. The company was acquired by Evolva in Nov, 2014, and Cargill contributed in financing of the deal.
Allylix's top competitors include Benson Hill, Cibus and Pairwise.
Allylix offers Slots, Live Casino, Sportsbook, Arcade, and 2 more products and services.
Allylix has 12 investors. Key investors include BASF, Tate & Lyle, Evolva, Pasadena Angels, and Tate & Lyle Ventures.
Yes. Allylix was acquired by Evolva in November 2014.